DOJ Claims Texas Pharmacy Co. Inflated Ingredient Pricing
A Houston pharmaceutical company cost the federal government hundreds of millions of dollars in excess reimbursements for prescription medicines by inflating the reported price of ingredients in violation of the False...To view the full article, register now.
Already a subscriber? Click here to view full article